FIELD: medicine, ophthalmology.
SUBSTANCE: one should analyze patient's genealogy, optic coherent tomography of ocular retina. According to tomogram one should evaluate the transparency of photoreceptors layer and its thickness, and, also, retinal thickness in the center. Under condition of autosomo-recessive type of inheritance and availability of retinal thickness in the center being 110±3.6 mcm and thickness of photoreceptors layer being 52.13±1.4 mcm it is possible to predict unfavourable disease flow. And under condition of autosomo-dominant type of inheritance and availability of retinal thickness in the center being 139±2.4 mcm, the thickness of photoreceptors layer being 73.43±2.6 mcm one should predict favorable disease flow. Moreover, in case of both flows of pigment retinitis the transparency of photoreceptors layer is shifted towards white color against standard chromatic scale of the device. The application of the present innovation enables to increase accuracy of detecting the above-mentioned disease in early juvenile age and provides the chance to evaluate its flow.
EFFECT: higher accuracy of prediction.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING PIGMENTED RETINITIS DEVELOPMENT STAGES | 2004 |
|
RU2267979C1 |
METHOD FOR PREDICTING VISUAL ACUITY IN RETINITIS PIGMENTOSA | 2022 |
|
RU2793420C1 |
METHOD FOR DETERMINING STAGES OF PIGMENT AND PIGMENTLESS PIGMENT RETINITIS | 2018 |
|
RU2707368C1 |
METHOD OF TREATMENT OF MACULAR EDEMA AT PATIENTS WITH PIGMENTAL RETINITIS | 2007 |
|
RU2338496C1 |
PDE6B GENE KNOCKOUT MOUSE MODEL CREATING AND APPLYING METHOD | 2022 |
|
RU2791687C1 |
ENZYMATIC TREATMENT OF RETINITIS PIGMENTOSA AND RELEVANT PHARMACEUTICAL COMPOSITION AS A KIT APPLIED FOR SUCH THERAPY | 2002 |
|
RU2304446C2 |
METHOD OF DIAGNOSTICS OF AUTOSOMAL-DOMINANT OPTIC NEUROPATHY | 2011 |
|
RU2491350C1 |
AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
REGIMEN AND METHODS OF TREATMENT OR REDUCTION OF VISUAL DISTURBANCES, ASSOCIATED WITH DEFICIENT ENDOGENOUS RETINOIDS | 2011 |
|
RU2622763C2 |
TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
Authors
Dates
2006-06-10—Published
2004-08-19—Filed